SHL Medical

Startseite
Schweiz
Zug
SHL Medical

SHL Medical is a pioneering leader in advanced self-injection solutions such as autoinjectors and pen injectors.

SHL Medical is a pioneering leader in self-injection solutions, such as autoinjectors. Headquartered in Switzerland with sites across three continents, we offer end-to-end services, from design and development to final assembly, labeling, and packaging, partnering with pharma companies to deliver self-injection systems that enable patients’ independence. View SHL Medical trademarks: https://www.shl-medical.com/trademarks

09/03/2026

Tokyo, we are back! 🗼

SHL Medical will be exhibiting at CPHI Japan 2026 from April 21-23 at Tokyo Big Sight.

This year, we will highlight recent developments within our self-injection device portfolio, reflecting how advances in device design and engineering support increasingly complex therapy requirements.

Visitors can explore solutions such as Quanta and Reunite alongside our broader portfolio, and exchange perspectives with our team on application considerations across different therapy and program needs.

06/03/2026

Sustainability is often associated with products and manufacturing. But it also shows up in everyday operational choices. ✨

One example is SHL Medical’s Pharmapack 2026 booth, which received Gold certification in the Better Stands Programme for a zero-waste setup. Our modular booth structure is designed to be reused across multiple events and supported by digital displays that help avoid single-use materials such as printed brochures or flyers.

The recognition highlights how sustainability is being considered across different parts of the organization, including how we design and deliver our presence at industry events. Applying circular thinking beyond development and manufacturing shows how incremental operational decisions can contribute to environmental progress.

05/03/2026

A strong first day in Suzhou, with thoughtful discussions around China’s autoinjector landscape.

One thing stood out in many conversations:
Device decisions today go beyond specifications.

Pharma teams are looking closely at what has already been proven in market, how reliably manufacturing can scale, and what kind of development support partners can provide.

Several priorities clearly shaped today’s discussions:
🔹Human factors and usability in autoinjector design
🔹Injection feedback mechanisms that support patient confidence
🔹Integrated solutions such as Needle Isolation Technology (NIT) that help simplify cartridge-based autoinjector use
🔹Regulatory readiness and IP protection as programs move toward commercialization

It’s encouraging to see how much attention is placed on usability, manufacturing readiness, and long-term partnership as autoinjector programs continue to expand across China.

Back on-site tomorrow.
If you’re in Suzhou, happy to exchange perspectives at Booth .

04/03/2026

On , we reflect on the real lives behind this global health crisis and the importance of long-term, sustainable care.

At SHL Medical, we have supported obesity care programs for over a decade through advancing our self-injection device technologies. From single-dose autoinjectors to multi-fixed-dose pen injectors, we focus on designing devices that are easy to use, provide consistent dosing, and can be manufactured reliably at scale, so patients have dependable access to care.

With our end-to-end device development expertise and global manufacturing footprint, we enable self-injection therapies to be delivered reliably, at scale, and where they are needed most. As obesity care increasingly becomes a long-term reality for growing populations, we remain committed to applying our expertise in ways that meaningfully support people living with obesity and contribute to better quality of life.

03/03/2026

Scaling device manufacturing is not just about producing more, but about maintaining control throughout the process. At SHL Medical, Operations Engineering teams develop and optimize the systems that make high-volume production possible, aligning automation, process design, and quality standards to ensure reliable manufacturing as we grow globally.

Delivering manufacturing reliability at scale depends on people who understand both engineering principles and real-world production environments. That’s why we invest in early-career talent, giving interns the opportunity to work alongside experienced engineers, contribute to real-world projects, and learn how robust production processes are built.

Meet our Taiwan teams on campus this weekend and at upcoming activities to see how our people and capabilities continue to grow together.

02/03/2026

In device development, risk mitigation has traditionally depended on physical testing. But testing typically happens only after design, tooling, and production setups are in place, making changes costly.

Simulation helps shift risk mitigation to earlier stages by assessing performance, screening concepts, and supporting better process decisions before major investment is made.

SHL Medical has been applying simulation across our device development value chain to strengthen our decision-making process. In this blog, we share what makes simulation programs effective, including the role of cross-functional processes and an uncertainty assessment framework. 👇

https://bit.ly/4aPzxyL

28/02/2026

Growth at SHL Medical often starts with saying yes to new challenges. For Bryan Lai, that journey began ten years ago, and it's still evolving. 💪

Today, Bryan focuses on bringing clarity and alignment to complex initiatives by connecting operational processes with digital solutions. Working closely with Operations, IT, and Quality, he helps turn strategic direction into structured action across SHL Medical’s global manufacturing network.

His work has supported projects ranging from the scale‑up of our North Charleston facility to preparations for our upcoming Swiss production site, collaborating with teams across the globe to keep progress moving forward.

What keeps him motivated? A fast-moving working environment, continuous learning, and the opportunity to step up where it matters, all while helping ensure reliable operations that ultimately support patients worldwide.

Explore your own growth journey at 👉 https://bit.ly/3Mx0HCp

27/02/2026

Reaching 1.5 billion autoinjectors shipped worldwide is a reflection of millions of therapy moments where reliability, simplicity, and trust matter.

Speaking with Torben Danger, CEO of SHL Medical Ulrich Fässler reflects on what this scale represents and what it signals for the future, not just in numbers but also in responsibility.

In healthcare, innovation isn’t defined by novelty alone. It’s defined by consistency at scale, by outcomes improved over time, and by the real lives supported along the way.

And it’s a perspective that continues to guide how SHL Medical approaches long-term impact in healthcare.

26/02/2026

SHL Medical achieves EcoVadis Gold! ✨

This achievement placed us among the top 5% of companies in our industry for sustainability performance. With a score of 80/100, we delivered strong results across all four assessed areas: Environment, Labor and Human Rights, Ethics, and Sustainable Procurement.

Here’s what powered our leap to Gold:
✅ Sustainable product innovation, including ISCC PLUS certification and integration of biobased materials
✅ Operational improvements, such as expanded renewable energy use and enhanced environmental data transparency
✅ Strengthened sustainability governance, including reinforced ethics and human rights policies and improved supply chain due diligence
✅ Greater transparency in how we track, manage, and report our sustainability progress

This marks an important milestone in our Sustainability Strategy 2030 journey, and we are committed to driving even greater impact across our global operations. https://bit.ly/4aXQAi7

25/02/2026

A lot of combination product work happens behind the scenes. Over the past 35+ years, SHL Medical has supported combination product launches across therapy areas.

Next week in Suzhou, we’ll be sharing what that experience looks like in practice, from program learnings to what pharma teams prioritize when planning for scale and launch.

See you at Booth .

24/02/2026

While design sets the direction of a great product, testing ensures that vision translates into reliable performance, resilience in real-world use, and regulatory confidence.

At SHL Medical, our Testing teams play a critical role in making that happen from early development through high-volume manufacturing. Working in our in-house testing labs, they continuously refine methods and expand our testing research database to strengthen how we support partners across the device lifecycle.

Through our internship program, we work closely with young professionals who help expand our testing expertise. Meet our Taiwan teams at upcoming campus activities to learn how our testing capabilities ensure quality at SHL Medical.

23/02/2026

As we continue to expand our global network and capabilities, DCAT Week provides the perfect setting to share how our latest advancements are shaping the future of drug delivery and contract manufacturing solutions.

From our enhanced final assembly, labeling, and packaging capabilities in Deerfield Beach to the continued growth of our North Charleston site, we’re strengthening the integrated, end‑to‑end services our partners rely on. These investments reflect a simple commitment: being ready to support customers with flexibility, scalability, and solutions built for tomorrow’s needs.

Our teams will be on‑site throughout the week to discuss how SHL Medical is expanding capabilities to align with evolving pharma and biotech requirements, whether it’s supporting late‑stage commercialization, exploring new device platforms, or scaling production to meet demand.

Find us at The Lexington Hotel NYC, Suite #2302. Let’s connect at DCAT Week and explore what we can achieve together.

Adresse

Gubelstrasse 22
Zug
6300

Webseite

http://www.shl-medical.com/, https://www.shl-medical.com/trademarks

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von SHL Medical erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Die Praxis Kontaktieren

Nachricht an SHL Medical senden:

Verknüpfungen

Wollen Sie Ihr Praxis zum Top-Klinik in Zug machen?

Our Story

SHL Medical is a world-leading provider of drug delivery solutions. We design, develop, and manufacture advanced drug delivery devices such as autoinjectors, pen injectors, and wearable drug delivery systems. We also offer design-to-build and contract manufacturing services for products such as laboratory handling equipment, neurosurgical devices, and industrial equipment.

By integrating our experienced development teams with efficient manufacturing and a skilled workforce, we have developed a successful business model that allows us to provide comprehensive solutions for demanding requirements of the industry. As the largest company in SHL Group, SHL Medical continues to offer experience, excellence, and vision to customers and partners all over the world.